Envestnet Asset Management
PBYI icon

Envestnet Asset Management’s Puma Biotechnology PBYI Stock Holding History

Envestnet Asset Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$237K Buy
29,190
+2,632
+10% +$19.3K ﹤0.01% 4569
2026
Q1 		$170K Buy
+26,558
New +$171K ﹤0.01% 4547
2021
Q4 		– Sell
-135,226
Closed -$948K – 3926
2021
Q3 		$948K Buy
135,226
+1,946
+1% +$14.6K ﹤0.01% 2580
2021
Q2 		$1.22M Buy
133,280
+5,518
+4% +$55.9K ﹤0.01% 2390
2021
Q1 		$1.24M Buy
127,762
+106,424
+499% +$1.19M ﹤0.01% 2239
2020
Q4 		$219K Buy
21,338
+360
+2% +$3.65K ﹤0.01% 3092
2020
Q3 		$212K Buy
20,978
+217
+1% +$2.21K ﹤0.01% 2891
2020
Q2 		$217K Sell
20,761
-1,296
-6% -$13.4K ﹤0.01% 2837
2020
Q1 		$186K Buy
22,057
+10,619
+93% +$103K ﹤0.01% 2750
2019
Q4 		$100K Buy
11,438
+219
+2% +$1.81K ﹤0.01% 2998
2019
Q3 		$121K Buy
+11,219
New +$121K ﹤0.01% 2942
2019
Q2 		– Sell
-6,536
Closed -$254K – 3065
2019
Q1 		$254K Buy
+6,536
New +$200K ﹤0.01% 2703
2018
Q3 		– Sell
-190
Closed -$11K – 2204
2018
Q2 		$11K Sell
190
-8
-4% -$464 ﹤0.01% 2520
2018
Q1 		$13K Buy
198
+55
+38% +$4.12K ﹤0.01% 2455
2017
Q4 		$14K Buy
143
+49
+52% +$5.48K ﹤0.01% 2573
2017
Q3 		$11K Buy
+94
New +$8.74K ﹤0.01% 2581
2016
Q3 		– Sell
-1,613
Closed -$48K – 3006
2016
Q2 		$48K Sell
1,613
-10
-0.6% -$313 ﹤0.01% 2747
2016
Q1 		$48K Buy
1,623
+420
+35% +$19K ﹤0.01% 2736
2015
Q4 		$94K Sell
1,203
-260
-18% -$20.4K ﹤0.01% 2392
2015
Q3 		$110K Buy
+1,463
New +$138K ﹤0.01% 2298
2014
Q4 		– Sell
-5
Closed -$1K – 2662
2014
Q3 		$1K Sell
5
-3
-38% -$616 ﹤0.01% 2632
2014
Q2 		$1K Hold
8
– – ﹤0.01% 2614
2014
Q1 		$1K Buy
+8
New +$940 ﹤0.01% 2436

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Envestnet Asset Management's PBYI Position: Q2 2026 in Review

Envestnet Asset Management increased its Puma Biotechnology (PBYI) stake by 9.9% in Q2 2026, buying an estimated $19.3K and bringing the position to 29,190 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #4569.

Envestnet Asset Management first reported a position in PBYI in Q1 2014 and has held it in 23 quarters since. The position peaked at $1.24M in Q1 2021. 160 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

  • Envestnet Asset Management held 29,190 shares of Puma Biotechnology worth $237K as of Q2 2026.
  • Envestnet Asset Management bought 2,632 Puma Biotechnology shares in Q2 2026, an estimated $19.3K.
  • Puma Biotechnology made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #4569 holding.
  • Envestnet Asset Management first reported a position in Puma Biotechnology in Q1 2014 and has held it in 23 quarters since.
  • Envestnet Asset Management's Puma Biotechnology position peaked at $1.24M in Q1 2021.
  • 160 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.